Skip to content

Ablacath™ Mapping Catheter

by Ablacon Inc.

510(k) K223666

Ablacath™ Mapping Catheter is a Class II device made by Ablacon Inc., cleared under FDA 510(k) K223666 on 17 Mar 2023, active as of 25 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 25 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK223666 Date17 Mar 2023ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MTD
FDA applicant
Ablacon, Inc.
Device class
Class II
Regulation
21 CFR Part 870.1220
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code MTD (Catheter, Intracardiac Mapping, High-Density Array).

Other devices from Ablacon Inc.

See all devices from Ablacon Inc. →